Katalog Plus
Bibliothek der Frankfurt UAS
Bald neuer Katalog: sichern Sie sich schon vorab Ihre persönlichen Merklisten im Nutzerkonto: Anleitung.
Dieses Ergebnis aus BASE kann Gästen nicht angezeigt werden.  Login für vollen Zugriff.

Prevention of SHIV transmission by topical IFN-β treatment

Title: Prevention of SHIV transmission by topical IFN-β treatment
Authors: Veazey, RS; Pilch Cooper, HA; Hope, TJ; Alter, G; Carias, AM; Sips, Magdalena; Wang, X; Rodriguez, B; Sieg, SF; Reich, A; Wilkinson, P; Cameron, MJ; Lederman, MM
Source: MUCOSAL IMMUNOLOGY ; ISSN: 1933-0219
Publication Year: 2016
Collection: Ghent University Academic Bibliography
Subject Terms: Medicine and Health Sciences; SIMIAN IMMUNODEFICIENCY VIRUS; INNATE IMMUNE-RESPONSE; HIV-1 INFECTION; RHESUS MACAQUES; T-CELLS; GENETIC-VARIATION; INTERFERON-ALPHA; SIV INFECTION; I INTERFERON; EXPRESSION
Description: Understanding vaginal and rectal HIV transmission and protective cellular and molecular mechanisms is critical for designing new prevention strategies, including those required for an effective vaccine. The determinants of protection against HIV infection are, however, poorly understood. Increasing evidence suggest that innate immune defenses may help protect mucosal surfaces from HIV transmission in highly exposed, uninfected subjects. More recent studies suggest that systemically administered type 1 interferon protects against simian immunodeficiency virus infection of macaques. Herewe hypothesized that topically applied type 1 interferons might stimulate vaginal innate responses that could protect against HIV transmission. We therefore applied a recombinant human type 1 interferon (IFN-b) to the vagina of rhesus macaques and vaginally challenged them with pathogenic simian/human immunodeficiency virus (SHIV). Vaginal administration of IFN-b resulted in marked local changes in immune cell phenotype, increasing immune activation and HIV co-receptor expression, yet provided significant protection from SHIV acquisition as interferon response genes were also upregulated. These data suggest that protection from vaginal HIV acquisition may be achieved by activating innate mucosal defenses.
Document Type: article in journal/newspaper
File Description: application/pdf
Language: English
Relation: https://biblio.ugent.be/publication/7072191; https://doi.org/10.1038/mi.2015.146; https://biblio.ugent.be/publication/7072191/file/7072205
DOI: 10.1038/mi.2015.146
Availability: https://biblio.ugent.be/publication/7072191; https://hdl.handle.net/1854/LU-7072191; https://doi.org/10.1038/mi.2015.146; https://biblio.ugent.be/publication/7072191/file/7072205
Rights: info:eu-repo/semantics/restrictedAccess
Accession Number: edsbas.2AEF9BDD
Database: BASE